Institutions / a16z Capital Management, L.L.C.

a16z Capital Management, L.L.C.

CIK 1540358 · Institution · as of Dec 31, 2025
Portfolio value
$1.58B
Positions
13
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Figma, Inc.FIGCommon Stock$607.12M16,246,12938.4%
Navan, Inc.NAVNCommon Stock$464.50M27,195,36429.4%
Meta Platforms Inc—$140.29M212,5318.9%
Revolution Medicines, Inc.—$73.37M921,0994.6%
Maze Therapeutics, Inc.—$70.52M1,702,2254.5%
Block, Inc.—$66.18M1,016,6974.2%
Omada Health, Inc.OMDACommon Stock$54.61M3,460,9293.5%
BioAge Labs, Inc.BIOACommon Stock$44.07M3,233,1702.8%
Nautilus Biotechnology, Inc.NAUTCommon Stock$34.43M17,653,9172.2%
Camp4 Therapeutics Corp—$13.03M2,125,3390.8%
Erasca, Inc.ERASCommon Stock$10.65M2,862,5000.7%
Ginkgo Bioworks Holdings, Inc.—$902.2K108,5680.1%
Heritage Commerce Corp—$129.1K82,7400.0%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.